The SBM Webinar: Conclusion A lot was said without anything being really said. But reading between the lines here is what I am getting at.
First the question regarding replacement for CEO: He said he will not stand in the way, meaning he is willing to step down if there is the right candidate. Fact is that they are looking, but they are not going to find anyone unless they deliver on AbbVie or animal health deal. No competent CEO will join the company unless there is a guaranteed revenue stream. Further a good CEO is not going to be cheap in a full time capacity :)
I think it is clear from their responses, that pretty much everything is on ice as of right now until money comes into the door. External advisors, marketing and management additions or replacement. That is also the reason why he was somewhat evasive on some of the questions. They are focusing on getting the animal deal done, because that would mean upfront and miles-stone payments.
All the questions regarding the AbbVie deal, pretty much evaporated, as their confidentiality agreement does not allow them to talk about it, they can not discuss or answer details of the deal. We can only speculate on the royalty payments and how high they will be, what will be the estimated total revenue of 1067 etc....
Chris: He was pretty upfront about it, looks like down the road there will be some sort of financing..... unless there is money from the animal health or AbbVie coming in. Dilution of 270 million shares already ... looks like we will be approaching the 300 million barrier.
I agree that it is good to have these webinars. However I think we should pool the questions in advance and come up with 5 key questions that we all want to have answered. So we can focus on the important things....